Award
NIH Reporter #11421859
Targeting HSPA Proteins in Advanced and Recurrent Endometrial Cancer Therapy
Recipient
Washington University
Award Amount
$212,525.00
Ceiling
$212,525.00
Awarded
August 26, 2026
Identifier
11421859
This award funds research on HSPA proteins targeting in advanced and recurrent endometrial cancer, focusing on drug SHetA2, clinical trials, and biomarker identification to improve therapy outcomes with reduced toxicity.
Description
The project involves studying a drug called SHetA2 for endometrial cancer treatment. The research includes mechanism studies, clinical trials, and biomarker identification. The project is funded by NIH/NCI under grant PAR-20-305. The award is for a multi-year period with a focus on improving therapies with reduced toxicity.